{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T12:00:20Z","timestamp":1794571220192,"version":"4.9.1"},"reference-count":106,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,1,28]],"date-time":"2025-01-28T00:00:00Z","timestamp":1738022400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,1,28]],"date-time":"2025-01-28T00:00:00Z","timestamp":1738022400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["U23A6010"],"award-info":[{"award-number":["U23A6010"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82394450"],"award-info":[{"award-number":["82394450"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82103037"],"award-info":[{"award-number":["82103037"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82090053"],"award-info":[{"award-number":["82090053"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82203643"],"award-info":[{"award-number":["82203643"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82172860"],"award-info":[{"award-number":["82172860"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82130077"],"award-info":[{"award-number":["82130077"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81961128025"],"award-info":[{"award-number":["81961128025"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["32370978"],"award-info":[{"award-number":["32370978"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003399","name":"Science and Technology Commission of Shanghai Municipality","doi-asserted-by":"publisher","award":["22YF1407200"],"award-info":[{"award-number":["22YF1407200"]}],"id":[{"id":"10.13039\/501100003399","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003399","name":"Science and Technology Commission of Shanghai Municipality","doi-asserted-by":"publisher","award":["19XD1420700"],"award-info":[{"award-number":["19XD1420700"]}],"id":[{"id":"10.13039\/501100003399","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003399","name":"Science and Technology Commission of Shanghai Municipality","doi-asserted-by":"publisher","award":["20XD1424900"],"award-info":[{"award-number":["20XD1424900"]}],"id":[{"id":"10.13039\/501100003399","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003399","name":"Science and Technology Commission of Shanghai Municipality","doi-asserted-by":"publisher","award":["2018SHZDZX05"],"award-info":[{"award-number":["2018SHZDZX05"]}],"id":[{"id":"10.13039\/501100003399","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002855","name":"Ministry of Science and Technology of the People's Republic of China","doi-asserted-by":"publisher","award":["2020YFA0509000"],"award-info":[{"award-number":["2020YFA0509000"]}],"id":[{"id":"10.13039\/501100002855","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002855","name":"Ministry of Science and Technology of the People's Republic of China","doi-asserted-by":"publisher","award":["2022YFA1302902"],"award-info":[{"award-number":["2022YFA1302902"]}],"id":[{"id":"10.13039\/501100002855","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Discov"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Dissecting the spatial heterogeneity of cancer-associated fibroblasts (CAFs) is vital for understanding tumor biology and therapeutic design. By combining pathological image analysis with spatial proteomics, we revealed two stromal archetypes in hepatocellular carcinoma (HCC) with different biological functions and extracellular matrix compositions. Using paired single-cell RNA and epigenomic sequencing with Stereo-seq, we revealed two fibroblast subsets CAF-FAP and CAF-C7, whose spatial enrichment strongly correlated with the two stromal archetypes and opposing patient prognosis. We discovered two functional units, one is the intratumor inflammatory hub featured by CAF-FAP plus CD8_PDCD1 proximity and the other is the marginal wound-healing hub with CAF-C7 plus Macrophage_SPP1 co-localization. Inhibiting CAF-FAP combined with anti-PD-1 in orthotopic HCC models led to improved tumor regression than either monotherapy. Collectively, our findings suggest stroma-targeted strategies for HCC based on defined stromal archetypes, raising the concept that CAFs change their transcriptional program and intercellular crosstalk according to the spatial context.<\/jats:p>","DOI":"10.1038\/s41421-024-00747-z","type":"journal-article","created":{"date-parts":[[2025,1,27]],"date-time":"2025-01-27T20:03:57Z","timestamp":1738008237000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":82,"title":["Stromal architecture and fibroblast subpopulations with opposing effects on outcomes in hepatocellular carcinoma"],"prefix":"10.1038","volume":"11","author":[{"given":"Yifei","family":"Cheng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaofang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7477-2984","authenticated-orcid":false,"given":"Zhicheng","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liyun","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bin","family":"Xiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1711-2933","authenticated-orcid":false,"given":"Xiaodong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2870-5187","authenticated-orcid":false,"given":"Dongbin","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Penghui","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jieyi","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9947-7268","authenticated-orcid":false,"given":"Guohe","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wulei","family":"Qian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Boan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8843-9426","authenticated-orcid":false,"given":"Yanan","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zheng","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lv","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingcheng","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiaqiang","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Youpei","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haichao","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lihua","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuebin","family":"Mao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Hou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingyu","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan","family":"Ji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoying","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2118-1117","authenticated-orcid":false,"given":"Jian","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5338-5173","authenticated-orcid":false,"given":"Xun","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiyang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5643-8739","authenticated-orcid":false,"given":"Wu","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6732-9132","authenticated-orcid":false,"given":"Xiaoming","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6695-9906","authenticated-orcid":false,"given":"Qiang","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7006-4737","authenticated-orcid":false,"given":"Hu","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4191-2917","authenticated-orcid":false,"given":"Yidi","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6857-7231","authenticated-orcid":false,"given":"Kui","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5158-629X","authenticated-orcid":false,"given":"Jia","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,1,28]]},"reference":[{"key":"747_CR1","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung, H. et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J. Clin. 71, 209\u2013249 (2021).","journal-title":"CA Cancer J. Clin."},{"key":"747_CR2","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1038\/s41572-020-00240-3","volume":"7","author":"JM Llovet","year":"2021","unstructured":"Llovet, J. M. et al. Hepatocellular carcinoma. Nat. Rev. Dis. Prim. 7, 6 (2021).","journal-title":"Nat. Rev. Dis. Prim."},{"key":"747_CR3","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1053\/j.gastro.2022.09.005","volume":"164","author":"PK Haber","year":"2023","unstructured":"Haber, P. K. et al. Molecular markers of response to anti-PD1 therapy in advanced hepatocellular carcinoma. Gastroenterology 164, 72\u201388.e18 (2023).","journal-title":"Gastroenterology"},{"key":"747_CR4","doi-asserted-by":"crossref","unstructured":"Baglieri, J., Brenner, D. A. & Kisseleva, T. The role of fibrosis and liver-associated fibroblasts in the pathogenesis of hepatocellular carcinoma. Int. J. Mol. Sci. 20, 1723 (2019).","DOI":"10.3390\/ijms20071723"},{"key":"747_CR5","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1038\/s41575-020-00372-7","volume":"18","author":"T Kisseleva","year":"2021","unstructured":"Kisseleva, T. & Brenner, D. Molecular and cellular mechanisms of liver fibrosis and its regression. Nat. Rev. Gastroenterol. Hepatol. 18, 151\u2013166 (2021).","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"747_CR6","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1016\/j.jhep.2023.01.011","volume":"78","author":"Y Liu","year":"2023","unstructured":"Liu, Y. et al. Identification of a tumour immune barrier in the HCC microenvironment that determines the efficacy of immunotherapy. J. Hepatol. 78, 770\u2013782 (2023).","journal-title":"J. Hepatol."},{"key":"747_CR7","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1038\/s41571-021-00546-5","volume":"18","author":"Y Chen","year":"2021","unstructured":"Chen, Y., McAndrews, K. M. & Kalluri, R. Clinical and therapeutic relevance of cancer-associated fibroblasts. Nat. Rev. Clin. Oncol. 18, 792\u2013804 (2021).","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"747_CR8","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1016\/j.ccell.2023.02.015","volume":"41","author":"G Caligiuri","year":"2023","unstructured":"Caligiuri, G. & Tuveson, D. A. Activated fibroblasts in cancer: Perspectives and challenges. Cancer Cell 41, 434\u2013449 (2023).","journal-title":"Cancer Cell"},{"key":"747_CR9","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1158\/1078-0432.CCR-22-1031","volume":"29","author":"KB Kennel","year":"2023","unstructured":"Kennel, K. B., Bozlar, M., De Valk, A. F. & Greten, F. R. Cancer-associated fibroblasts in inflammation and antitumor immunity. Clin. Cancer Res. 29, 1009\u20131016 (2023).","journal-title":"Clin. Cancer Res."},{"key":"747_CR10","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1038\/nm.4123","volume":"22","author":"H Jiang","year":"2016","unstructured":"Jiang, H. et al. Targeting focal adhesion kinase renders pancreatic cancers responsive to checkpoint immunotherapy. Nat. Med. 22, 851\u2013860 (2016).","journal-title":"Nat. Med."},{"key":"747_CR11","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1038\/s41586-022-05272-1","volume":"611","author":"AT Krishnamurty","year":"2022","unstructured":"Krishnamurty, A. T. et al. LRRC15(+) myofibroblasts dictate the stromal setpoint to suppress tumour immunity. Nature 611, 148\u2013154 (2022).","journal-title":"Nature"},{"key":"747_CR12","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/S0140-6736(88)90686-1","volume":"2","author":"LC Barr","year":"1988","unstructured":"Barr, L. C., Carter, R. L. & Davies, A. J. Encapsulation of tumours as a modified wound healing response. Lancet 2, 135\u2013137 (1988).","journal-title":"Lancet"},{"key":"747_CR13","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1002\/hep.1840110516","volume":"11","author":"EC Lai","year":"1990","unstructured":"Lai, E. C. et al. Long-term results of resection for large hepatocellular carcinoma: a multivariate analysis of clinicopathological features. Hepatology 11, 815\u2013818 (1990).","journal-title":"Hepatology"},{"key":"747_CR14","doi-asserted-by":"publisher","first-page":"2539","DOI":"10.1245\/s10434-009-0453-1","volume":"16","author":"T Iguchi","year":"2009","unstructured":"Iguchi, T. et al. Both fibrous capsule formation and extracapsular penetration are powerful predictors of poor survival in human hepatocellular carcinoma: a histological assessment of 365 patients in Japan. Ann. Surg. Oncol. 16, 2539\u20132546 (2009).","journal-title":"Ann. Surg. Oncol."},{"key":"747_CR15","doi-asserted-by":"publisher","first-page":"1960","DOI":"10.1126\/science.1129139","volume":"313","author":"J Galon","year":"2006","unstructured":"Galon, J. et al. Type, density, and location of immune cells within human colorectal tumors predict clinical outcome. Science 313, 1960\u20131964 (2006).","journal-title":"Science"},{"key":"747_CR16","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1038\/s41573-018-0007-y","volume":"18","author":"J Galon","year":"2019","unstructured":"Galon, J. & Bruni, D. Approaches to treat immune hot, altered and cold tumours with combination immunotherapies. Nat. Rev. Drug Discov. 18, 197\u2013218 (2019).","journal-title":"Nat. Rev. Drug Discov."},{"key":"747_CR17","doi-asserted-by":"publisher","first-page":"2586","DOI":"10.1200\/JCO.2006.09.4565","volume":"25","author":"Q Gao","year":"2007","unstructured":"Gao, Q. et al. Intratumoral balance of regulatory and cytotoxic T cells is associated with prognosis of hepatocellular carcinoma after resection. J. Clin. Oncol. 25, 2586\u20132593 (2007).","journal-title":"J. Clin. Oncol."},{"key":"747_CR18","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1038\/s41590-020-0635-3","volume":"21","author":"AT Krishnamurty","year":"2020","unstructured":"Krishnamurty, A. T. & Turley, S. J. Lymph node stromal cells: cartographers of the immune system. Nat. Immunol. 21, 369\u2013380 (2020).","journal-title":"Nat. Immunol."},{"key":"747_CR19","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1016\/j.tcb.2021.11.008","volume":"32","author":"M Kochetkova","year":"2022","unstructured":"Kochetkova, M. & Samuel, M. S. Differentiation of the tumor microenvironment: are CAFs the Organizer? Trends Cell Biol. 32, 285\u2013294 (2022).","journal-title":"Trends Cell Biol."},{"key":"747_CR20","doi-asserted-by":"publisher","first-page":"2094","DOI":"10.1158\/1078-0432.CCR-21-3570","volume":"28","author":"A Obradovic","year":"2022","unstructured":"Obradovic, A. et al. Immunostimulatory cancer-associated fibroblast subpopulations can predict immunotherapy response in head and neck Cancer. Clin. Cancer Res. 28, 2094\u20132109 (2022).","journal-title":"Clin. Cancer Res."},{"key":"747_CR21","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1158\/2159-8290.CD-19-0644","volume":"10","author":"CX Dominguez","year":"2020","unstructured":"Dominguez, C. X. et al. Single-cell RNA sequencing reveals stromal evolution into LRRC15(+) myofibroblasts as a determinant of patient response to cancer immunotherapy. Cancer Discov. 10, 232\u2013253 (2020).","journal-title":"Cancer Discov."},{"key":"747_CR22","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1038\/s41421-021-00271-4","volume":"7","author":"Y Wang","year":"2021","unstructured":"Wang, Y. et al. Single-cell analysis of pancreatic ductal adenocarcinoma identifies a novel fibroblast subtype associated with poor prognosis but better immunotherapy response. Cell Discov. 7, 36 (2021).","journal-title":"Cell Discov."},{"key":"747_CR23","unstructured":"Pelka, K. et al. Spatially organized multicellular immune hubs in human colorectal cancer. Cell 184, 4734\u20134752.e20 (2021)."},{"key":"747_CR24","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1038\/s41586-022-05400-x","volume":"612","author":"R Xue","year":"2022","unstructured":"Xue, R. et al. Liver tumour immune microenvironment subtypes and neutrophil heterogeneity. Nature 612, 141\u2013147 (2022).","journal-title":"Nature"},{"key":"747_CR25","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1038\/s41421-023-00529-z","volume":"9","author":"GQ Zhu","year":"2023","unstructured":"Zhu, G. Q. et al. CD36(+) cancer-associated fibroblasts provide immunosuppressive microenvironment for hepatocellular carcinoma via secretion of macrophage migration inhibitory factor. Cell Discov. 9, 25 (2023).","journal-title":"Cell Discov."},{"key":"747_CR26","doi-asserted-by":"crossref","unstructured":"Sharma, A. et al. Onco-fetal reprogramming of endothelial cells drives immunosuppressive macrophages in hepatocellular carcinoma. Cell 183, 377\u2013394.e21 (2020).","DOI":"10.1016\/j.cell.2020.08.040"},{"key":"747_CR27","doi-asserted-by":"crossref","unstructured":"Sun, Y. et al. Single-cell landscape of the ecosystem in early-relapse hepatocellular carcinoma. Cell 184, 404\u2013421.e16 (2021).","DOI":"10.1016\/j.cell.2020.11.041"},{"key":"747_CR28","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-35291-5","volume":"13","author":"L Ma","year":"2022","unstructured":"Ma, L. et al. Multiregional single-cell dissection of tumor and immune cells reveals stable lock-and-key features in liver cancer. Nat. Commun. 13, 7533 (2022).","journal-title":"Nat. Commun."},{"key":"747_CR29","doi-asserted-by":"publisher","first-page":"1397","DOI":"10.1016\/j.jhep.2021.06.028","volume":"75","author":"L Ma","year":"2021","unstructured":"Ma, L. et al. Single-cell atlas of tumor cell evolution in response to therapy in hepatocellular carcinoma and intrahepatic cholangiocarcinoma. J. Hepatol. 75, 1397\u20131408 (2021).","journal-title":"J. Hepatol."},{"key":"747_CR30","unstructured":"Chen, A. et al. Spatiotemporal transcriptomic atlas of mouse organogenesis using DNA nanoball-patterned arrays. Cell 185, 1777\u20131792.e21 (2022)."},{"key":"747_CR31","doi-asserted-by":"publisher","first-page":"1390","DOI":"10.1038\/s41588-022-01157-1","volume":"54","author":"D Cui Zhou","year":"2022","unstructured":"Cui Zhou, D. et al. Spatially restricted drivers and transitional cell populations cooperate with the microenvironment in untreated and chemo-resistant pancreatic cancer. Nat. Genet. 54, 1390\u20131405 (2022).","journal-title":"Nat. Genet."},{"key":"747_CR32","doi-asserted-by":"publisher","first-page":"eabp8964","DOI":"10.1126\/science.abp8964","volume":"379","author":"TE Sutherland","year":"2023","unstructured":"Sutherland, T. E., Dyer, D. P. & Allen, J. E. The extracellular matrix and the immune system: a mutually dependent relationship. Science 379, eabp8964 (2023).","journal-title":"Science"},{"key":"747_CR33","doi-asserted-by":"crossref","unstructured":"Gr\u00fcnwald, B. T. et al. Spatially confined sub-tumor microenvironments in pancreatic cancer. Cell 184, 5577\u20135592.e18 (2021).","DOI":"10.1016\/j.cell.2021.09.022"},{"key":"747_CR34","doi-asserted-by":"crossref","unstructured":"Gao, Q. et al. Integrated proteogenomic characterization of HBV-related hepatocellular carcinoma. Cell 179, 561\u2013577.e22 (2019).","DOI":"10.1016\/j.cell.2019.08.052"},{"key":"747_CR35","doi-asserted-by":"crossref","unstructured":"Shi, J. Y. et al. Exploring prognostic indicators in the pathological images of hepatocellular carcinoma based on deep learning. Gut 70, 951\u2013961 (2021).","DOI":"10.1136\/gutjnl-2020-320930"},{"key":"747_CR36","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1002\/jso.22060","volume":"105","author":"TH Wu","year":"2012","unstructured":"Wu, T. H. et al. Encapsulation is a significant prognostic factor for better outcome in large hepatocellular carcinoma. J. Surg. Oncol. 105, 85\u201390 (2012).","journal-title":"J. Surg. Oncol."},{"key":"747_CR37","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1245\/s10434-013-3211-3","volume":"21","author":"DJ Arnaoutakis","year":"2014","unstructured":"Arnaoutakis, D. J. et al. Recurrence patterns and prognostic factors in patients with hepatocellular carcinoma in noncirrhotic liver: a multi-institutional analysis. Ann. Surg. Oncol. 21, 147\u2013154 (2014).","journal-title":"Ann. Surg. Oncol."},{"key":"747_CR38","doi-asserted-by":"publisher","first-page":"5994","DOI":"10.1158\/1078-0432.CCR-12-3497","volume":"19","author":"JY Shi","year":"2013","unstructured":"Shi, J. Y. et al. Margin-infiltrating CD20(+) B cells display an atypical memory phenotype and correlate with favorable prognosis in hepatocellular carcinoma. Clin. Cancer Res. 19, 5994\u20136005 (2013).","journal-title":"Clin. Cancer Res."},{"key":"747_CR39","doi-asserted-by":"crossref","unstructured":"Montironi, C. et al. Inflamed and non-inflamed classes of HCC: a revised immunogenomic classification. Gut 72, 129\u2013140 (2023).","DOI":"10.1136\/gutjnl-2021-325918"},{"key":"747_CR40","doi-asserted-by":"crossref","unstructured":"Li, B. et al. Letter to the editor: the inflamed subclass predicts immunotherapy response - external validations. Gut 72, 1224\u20131226 (2023).","DOI":"10.1136\/gutjnl-2022-328130"},{"key":"747_CR41","doi-asserted-by":"publisher","first-page":"1460","DOI":"10.1016\/j.jhep.2020.07.026","volume":"73","author":"B Sangro","year":"2020","unstructured":"Sangro, B. et al. Association of inflammatory biomarkers with clinical outcomes in nivolumab-treated patients with advanced hepatocellular carcinoma. J. Hepatol. 73, 1460\u20131469 (2020).","journal-title":"J. Hepatol."},{"key":"747_CR42","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms3612","volume":"4","author":"K Yoshihara","year":"2013","unstructured":"Yoshihara, K. et al. Inferring tumour purity and stromal and immune cell admixture from expression data. Nat. Commun. 4, 2612 (2013).","journal-title":"Nat. Commun."},{"key":"747_CR43","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1038\/s41586-019-1004-y","volume":"567","author":"JW Lee","year":"2019","unstructured":"Lee, J. W. et al. Hepatocytes direct the formation of a pro-metastatic niche in the liver. Nature 567, 249\u2013252 (2019).","journal-title":"Nature"},{"key":"747_CR44","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1038\/s41422-023-00831-1","volume":"33","author":"L Wu","year":"2023","unstructured":"Wu, L. et al. An invasive zone in human liver cancer identified by Stereo-seq promotes hepatocyte-tumor cell crosstalk, local immunosuppression and tumor progression. Cell Res. 33, 585\u2013603 (2023).","journal-title":"Cell Res."},{"key":"747_CR45","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1038\/s41568-020-00329-7","volume":"21","author":"TR Cox","year":"2021","unstructured":"Cox, T. R. The matrix in cancer. Nat. Rev. Cancer 21, 217\u2013238 (2021).","journal-title":"Nat. Rev. Cancer"},{"key":"747_CR46","doi-asserted-by":"crossref","unstructured":"Salmon, H. et al. Matrix architecture defines the preferential localization and migration of T cells into the stroma of human lung tumors. J. Clin. Invest. 122, 899\u2013910 (2012).","DOI":"10.1172\/JCI45817"},{"key":"747_CR47","doi-asserted-by":"publisher","first-page":"2606","DOI":"10.1158\/2159-8290.CD-21-1714","volume":"12","author":"JA Grout","year":"2022","unstructured":"Grout, J. A. et al. Spatial positioning and matrix programs of cancer-associated fibroblasts promote T cell exclusion in human lung tumors. Cancer Discov. 12, 2606\u20132625 (2022).","journal-title":"Cancer Discov."},{"key":"747_CR48","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1016\/j.jhep.2020.08.033","volume":"74","author":"M Winkler","year":"2021","unstructured":"Winkler, M. et al. Endothelial GATA4 controls liver fibrosis and regeneration by preventing a pathogenic switch in angiocrine signaling. J. Hepatol. 74, 380\u2013393 (2021).","journal-title":"J. Hepatol."},{"key":"747_CR49","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1038\/s41421-023-00529-z","volume":"9","author":"G-Q Zhu","year":"2023","unstructured":"Zhu, G.-Q. et al. CD36+ cancer-associated fibroblasts provide immunosuppressive microenvironment for hepatocellular carcinoma via secretion of macrophage migration inhibitory factor. Cell Discov. 9, 25 (2023).","journal-title":"Cell Discov."},{"key":"747_CR50","doi-asserted-by":"publisher","first-page":"2194","DOI":"10.1158\/1078-0432.CCR-18-1955","volume":"25","author":"V Bernard","year":"2019","unstructured":"Bernard, V. et al. Single-cell transcriptomics of pancreatic cancer precursors demonstrates epithelial and microenvironmental heterogeneity as an early event in neoplastic Progression. Clin. Cancer Res. 25, 2194\u20132205 (2019).","journal-title":"Clin. Cancer Res."},{"key":"747_CR51","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1038\/s41586-019-1631-3","volume":"575","author":"P Ramachandran","year":"2019","unstructured":"Ramachandran, P. et al. Resolving the fibrotic niche of human liver cirrhosis at single-cell level. Nature 575, 512\u2013518 (2019).","journal-title":"Nature"},{"key":"747_CR52","doi-asserted-by":"crossref","unstructured":"Yang, W. et al. Single\u2010cell transcriptomic analysis reveals a hepatic stellate cell\u2013activation roadmap and myofibroblast origin during liver fibrosis in mice. Hepatology 74, 2774\u20132790 (2021).","DOI":"10.1002\/hep.31987"},{"key":"747_CR53","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1038\/s41586-022-05289-6","volume":"610","author":"A Filliol","year":"2022","unstructured":"Filliol, A. et al. Opposing roles of hepatic stellate cell subpopulations in hepatocarcinogenesis. Nature 610, 356\u2013365 (2022).","journal-title":"Nature"},{"key":"747_CR54","doi-asserted-by":"crossref","unstructured":"Hoogstrate, Y. et al. Transcriptome analysis reveals tumor microenvironment changes in glioblastoma. Cancer Cell 41, 678\u2013692.e7 (2023).","DOI":"10.1016\/j.ccell.2023.02.019"},{"key":"747_CR55","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-26259-y","volume":"12","author":"Y-M Meng","year":"2021","unstructured":"Meng, Y.-M. et al. Hexokinase 2-driven glycolysis in pericytes activates their contractility leading to tumor blood vessel abnormalities. Nat. Commun. 12, 6011 (2021).","journal-title":"Nat. Commun."},{"key":"747_CR56","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1038\/s43018-023-00672-2","volume":"5","author":"Z Li","year":"2024","unstructured":"Li, Z. et al. Presence of onco-fetal neighborhoods in hepatocellular carcinoma is associated with relapse and response to immunotherapy. Nat. Cancer 5, 167\u2013186 (2024).","journal-title":"Nat. Cancer"},{"key":"747_CR57","doi-asserted-by":"publisher","first-page":"1102","DOI":"10.1158\/2159-8290.CD-19-0094","volume":"9","author":"E Elyada","year":"2019","unstructured":"Elyada, E. et al. Cross-species single-cell analysis of pancreatic ductal adenocarcinoma reveals antigen-presenting cancer-associated fibroblasts. Cancer Discov. 9, 1102\u20131123 (2019).","journal-title":"Cancer Discov."},{"key":"747_CR58","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-29366-6","volume":"13","author":"J Qi","year":"2022","unstructured":"Qi, J. et al. Single-cell and spatial analysis reveal interaction of FAP+ fibroblasts and SPP1+ macrophages in colorectal cancer. Nat. Commun. 13, 1742 (2022).","journal-title":"Nat. Commun."},{"key":"747_CR59","doi-asserted-by":"publisher","first-page":"1580","DOI":"10.1158\/2159-8290.CD-20-1484","volume":"12","author":"KM McAndrews","year":"2022","unstructured":"McAndrews, K. M. et al. Identification of functional heterogeneity of carcinoma-associated fibroblasts with distinct IL-6 mediated therapy resistance in pancreatic cancer. Cancer Discov. 12, 1580\u20131597 (2022).","journal-title":"Cancer Discov."},{"key":"747_CR60","doi-asserted-by":"crossref","unstructured":"Wang, H. et al. Antiandrogen treatment induces stromal cell reprogramming to promote castration resistance in prostate cancer. Cancer Cell 41, 1345\u20131362.e9 (2023).","DOI":"10.1016\/j.ccell.2023.05.016"},{"key":"747_CR61","doi-asserted-by":"publisher","first-page":"1578","DOI":"10.1002\/hep.31848","volume":"74","author":"SS Wang","year":"2021","unstructured":"Wang, S. S. et al. Perivenous stellate cells are the main source of myofibroblasts and cancer-associated fibroblasts formed after chronic liver injuries. Hepatology 74, 1578\u20131594 (2021).","journal-title":"Hepatology"},{"key":"747_CR62","doi-asserted-by":"crossref","unstructured":"Dilshat, R. et al. MITF reprograms the extracellular matrix and focal adhesion in melanoma. Elife. 10, e63093 (2021).","DOI":"10.7554\/eLife.63093"},{"key":"747_CR63","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1038\/s41588-022-01088-x","volume":"54","author":"WR Becker","year":"2022","unstructured":"Becker, W. R. et al. Single-cell analyses define a continuum of cell state and composition changes in the malignant transformation of polyps to colorectal cancer. Nat. Genet. 54, 985\u2013995 (2022).","journal-title":"Nat. Genet."},{"key":"747_CR64","doi-asserted-by":"crossref","unstructured":"Foster, D. S. et al. Multiomic analysis reveals conservation of cancer-associated fibroblast phenotypes across species and tissue of origin. Cancer Cell 40, 1392\u20131406.e7 (2022).","DOI":"10.1016\/j.ccell.2022.09.015"},{"key":"747_CR65","doi-asserted-by":"publisher","first-page":"101750","DOI":"10.1016\/j.redox.2020.101750","volume":"37","author":"TF Chi","year":"2020","unstructured":"Chi, T. F. et al. Loss of USF2 promotes proliferation, migration and mitophagy in a redox-dependent manner. Redox Biol. 37, 101750 (2020).","journal-title":"Redox Biol."},{"key":"747_CR66","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.yexcr.2004.08.013","volume":"302","author":"C Choe","year":"2005","unstructured":"Choe, C., Chen, N. & Sawadogo, M. Decreased tumorigenicity of c-Myc-transformed fibroblasts expressing active USF2. Exp. Cell Res. 302, 1\u201310 (2005).","journal-title":"Exp. Cell Res."},{"key":"747_CR67","doi-asserted-by":"crossref","unstructured":"Santos, A. M. et al. Targeting fibroblast activation protein inhibits tumor stromagenesis and growth in mice. J. Clin. Invest. 119, 3613\u20133625 (2009).","DOI":"10.1172\/JCI38988"},{"key":"747_CR68","doi-asserted-by":"publisher","first-page":"1518","DOI":"10.1158\/2159-8290.CD-21-1357","volume":"12","author":"AJ Nirmal","year":"2022","unstructured":"Nirmal, A. J. et al. The spatial landscape of progression and immunoediting in primary melanoma at single-cell resolution. Cancer Discov. 12, 1518\u20131541 (2022).","journal-title":"Cancer Discov."},{"key":"747_CR69","doi-asserted-by":"crossref","unstructured":"Ben-Porath, I. et al. An embryonic stem cell-like gene expression signature in poorly differentiated aggressive human tumors. Nat. Genet. 40, 499\u2013507 (2008).","DOI":"10.1038\/ng.127"},{"key":"747_CR70","doi-asserted-by":"crossref","unstructured":"Zhou, L. et al. Lineage tracing and single-cell analysis reveal proliferative Prom1+ tumour-propagating cells and their dynamic cellular transition during liver cancer progression. Gut 71, 1656\u20131668 (2022).","DOI":"10.1136\/gutjnl-2021-324321"},{"key":"747_CR71","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1038\/s41586-021-04057-2","volume":"599","author":"X Sun","year":"2021","unstructured":"Sun, X. et al. Tumour DDR1 promotes collagen fibre alignment to instigate immune exclusion. Nature 599, 673\u2013678 (2021).","journal-title":"Nature"},{"key":"747_CR72","doi-asserted-by":"publisher","first-page":"eadd8945","DOI":"10.1126\/sciimmunol.add8945","volume":"8","author":"T Fabre","year":"2023","unstructured":"Fabre, T. et al. Identification of a broadly fibrogenic macrophage subset induced by type 3 inflammation. Sci. Immunol. 8, eadd8945 (2023).","journal-title":"Sci. Immunol."},{"key":"747_CR73","doi-asserted-by":"crossref","unstructured":"Zhang, Q. et al. Landscape and dynamics of single immune cells in hepatocellular carcinoma. Cell 179, 829\u2013845.e20 (2019).","DOI":"10.1016\/j.cell.2019.10.003"},{"key":"747_CR74","unstructured":"Wienke, J. et al. Integrative analysis of neuroblastoma by single-cell RNA sequencing identifies the NECTIN2-TIGIT axis as a target for immunotherapy. Cancer Cell 42, 283\u2013300.e8 (2024)."},{"key":"747_CR75","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1016\/j.ccell.2014.10.018","volume":"26","author":"RJ Johnston","year":"2014","unstructured":"Johnston, R. J. et al. The immunoreceptor TIGIT regulates antitumor and antiviral CD8(+) T cell effector function. Cancer Cell 26, 923\u2013937 (2014).","journal-title":"Cancer Cell"},{"key":"747_CR76","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1038\/s41586-021-03549-5","volume":"593","author":"MB Buechler","year":"2021","unstructured":"Buechler, M. B. et al. Cross-tissue organization of the fibroblast lineage. Nature 593, 575\u2013579 (2021).","journal-title":"Nature"},{"key":"747_CR77","doi-asserted-by":"crossref","unstructured":"Luo, H. et al. Characterizing dedifferentiation of thyroid cancer by integrated analysis. Sci. Adv. 7, eabf3657 (2021).","DOI":"10.1126\/sciadv.abf3657"},{"key":"747_CR78","doi-asserted-by":"publisher","first-page":"2640","DOI":"10.1158\/1078-0432.CCR-19-3231","volume":"26","author":"A Sathe","year":"2020","unstructured":"Sathe, A. et al. Single-cell genomic characterization reveals the cellular reprogramming of the gastric tumor microenvironment. Clin. Cancer Res. 26, 2640\u20132653 (2020).","journal-title":"Clin. Cancer Res."},{"key":"747_CR79","doi-asserted-by":"crossref","unstructured":"Li, H. et al. Single-cell transcriptomic architecture unraveling the complexity of tumor heterogeneity in distal cholangiocarcinoma. Cell Mol. Gastroenterol. Hepatol. 13, 1592\u20131609.e9 (2022).","DOI":"10.1016\/j.jcmgh.2022.02.014"},{"key":"747_CR80","doi-asserted-by":"publisher","DOI":"10.1186\/s13073-020-00776-9","volume":"12","author":"W Lin","year":"2020","unstructured":"Lin, W. et al. Single-cell transcriptome analysis of tumor and stromal compartments of pancreatic ductal adenocarcinoma primary tumors and metastatic lesions. Genome Med. 12, 80 (2020).","journal-title":"Genome Med."},{"key":"747_CR81","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1038\/s41422-019-0195-y","volume":"29","author":"J Peng","year":"2019","unstructured":"Peng, J. et al. Single-cell RNA-seq highlights intra-tumoral heterogeneity and malignant progression in pancreatic ductal adenocarcinoma. Cell Res. 29, 725\u2013738 (2019).","journal-title":"Cell Res"},{"key":"747_CR82","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1038\/s41422-020-0355-0","volume":"30","author":"J Qian","year":"2020","unstructured":"Qian, J. et al. A pan-cancer blueprint of the heterogeneous tumor microenvironment revealed by single-cell profiling. Cell Res. 30, 745\u2013762 (2020).","journal-title":"Cell Res."},{"key":"747_CR83","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-16164-1","volume":"11","author":"N Kim","year":"2020","unstructured":"Kim, N. et al. Single-cell RNA sequencing demonstrates the molecular and cellular reprogramming of metastatic lung adenocarcinoma. Nat. Commun. 11, 2285 (2020).","journal-title":"Nat. Commun."},{"key":"747_CR84","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1158\/2326-6066.CIR-13-0027","volume":"2","author":"LC Wang","year":"2014","unstructured":"Wang, L. C. et al. Targeting fibroblast activation protein in tumor stroma with chimeric antigen receptor T cells can inhibit tumor growth and augment host immunity without severe toxicity. Cancer Immunol. Res. 2, 154\u2013166 (2014).","journal-title":"Cancer Immunol. Res."},{"key":"747_CR85","doi-asserted-by":"publisher","first-page":"1192","DOI":"10.1038\/s41588-022-01141-9","volume":"54","author":"D Barkley","year":"2022","unstructured":"Barkley, D. et al. Cancer cell states recur across tumor types and form specific interactions with the tumor microenvironment. Nat. Genet. 54, 1192\u20131201 (2022).","journal-title":"Nat. Genet."},{"key":"747_CR86","doi-asserted-by":"publisher","DOI":"10.1186\/s13073-023-01218-y","volume":"15","author":"S Zhang","year":"2023","unstructured":"Zhang, S. et al. Spatial transcriptomics analysis of neoadjuvant cabozantinib and nivolumab in advanced hepatocellular carcinoma identifies independent mechanisms of resistance and recurrence. Genome Med. 15, 72 (2023).","journal-title":"Genome Med."},{"key":"747_CR87","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1016\/j.gpb.2022.08.004","volume":"21","author":"Z Chen","year":"2023","unstructured":"Chen, Z. et al. TIGER: a web portal of tumor immunotherapy gene expression resource. Genomics Proteom. Bioinforma. 21, 337\u2013348 (2023).","journal-title":"Genomics Proteom. Bioinforma."},{"key":"747_CR88","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1016\/j.trecan.2022.02.007","volume":"8","author":"J Almagro","year":"2022","unstructured":"Almagro, J. et al. Tissue architecture in tumor initiation and progression. Trends Cancer 8, 494\u2013505 (2022).","journal-title":"Trends Cancer"},{"key":"747_CR89","doi-asserted-by":"publisher","first-page":"2116","DOI":"10.1158\/1078-0432.CCR-18-2293","volume":"25","author":"JJ Harding","year":"2019","unstructured":"Harding, J. J. et al. Prospective genotyping of hepatocellular carcinoma: clinical implications of next-generation sequencing for matching patients to targeted and immune therapies. Clin. Cancer Res. 25, 2116\u20132126 (2019).","journal-title":"Clin. Cancer Res."},{"key":"747_CR90","doi-asserted-by":"publisher","first-page":"1599","DOI":"10.1038\/s41591-022-01868-2","volume":"28","author":"AX Zhu","year":"2022","unstructured":"Zhu, A. X. et al. Molecular correlates of clinical response and resistance to atezolizumab in combination with bevacizumab in advanced hepatocellular carcinoma. Nat. Med. 28, 1599\u20131611 (2022).","journal-title":"Nat. Med."},{"key":"747_CR91","doi-asserted-by":"crossref","unstructured":"Benci, J. L. et al. Tumor interferon signaling regulates a multigenic resistance program to immune checkpoint blockade. Cell 167, 1540\u20131554.e12 (2016).","DOI":"10.1016\/j.cell.2016.11.022"},{"key":"747_CR92","doi-asserted-by":"crossref","unstructured":"Benci, J. L. et al. Opposing functions of interferon coordinate adaptive and innate immune responses to cancer immune checkpoint blockade. Cell 178, 933\u2013948.e14 (2019).","DOI":"10.1016\/j.cell.2019.07.019"},{"key":"747_CR93","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1038\/s41422-019-0224-x","volume":"29","author":"N Jacquelot","year":"2019","unstructured":"Jacquelot, N. et al. Sustained type I interferon signaling as a mechanism of resistance to PD-1 blockade. Cell Res. 29, 846\u2013861 (2019).","journal-title":"Cell Res."},{"key":"747_CR94","doi-asserted-by":"publisher","first-page":"1495","DOI":"10.1038\/s41590-022-01315-x","volume":"23","author":"J Dubrot","year":"2022","unstructured":"Dubrot, J. et al. In vivo CRISPR screens reveal the landscape of immune evasion pathways across cancer. Nat. Immunol. 23, 1495\u20131506 (2022).","journal-title":"Nat. Immunol."},{"key":"747_CR95","doi-asserted-by":"crossref","unstructured":"Memon, D. et al. Clinical and molecular features of acquired resistance to immunotherapy in non-small cell lung cancer. Cancer Cell 42, 209\u2013224.e9 (2024).","DOI":"10.1016\/j.ccell.2023.12.013"},{"key":"747_CR96","first-page":"43","volume":"4","author":"J Qiu","year":"2023","unstructured":"Qiu, J. et al. Cancer cells resistant to immune checkpoint blockade acquire interferon-associated epigenetic memory to sustain T cell dysfunction. Nat. Cancer 4, 43\u201361 (2023).","journal-title":"Nat. Cancer"},{"key":"747_CR97","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1126\/science.1195300","volume":"330","author":"M Kraman","year":"2010","unstructured":"Kraman, M. et al. Suppression of antitumor immunity by stromal cells expressing fibroblast activation protein-alpha. Science 330, 827\u2013830 (2010).","journal-title":"Science"},{"key":"747_CR98","doi-asserted-by":"crossref","unstructured":"Feig, C. et al. Targeting CXCL12 from FAP-expressing carcinoma-associated fibroblasts synergizes with anti-PD-L1 immunotherapy in pancreatic cancer. Proc. Natl. Acad. Sci. USA 110, 20212\u201320217 (2013).","DOI":"10.1073\/pnas.1320318110"},{"key":"747_CR99","doi-asserted-by":"publisher","first-page":"1580","DOI":"10.1158\/2159-8290.CD-20-1484","volume":"12","author":"KM McAndrews","year":"2022","unstructured":"McAndrews, K. M. et al. Identification of functional heterogeneity of carcinoma-associated fibroblasts with distinct IL6-mediated therapy resistance in pancreatic cancer. Cancer Discov. 12, 1580\u20131597 (2022).","journal-title":"Cancer Discov."},{"key":"747_CR100","doi-asserted-by":"publisher","first-page":"4036","DOI":"10.1158\/1078-0432.CCR-20-4001","volume":"27","author":"E Sum","year":"2021","unstructured":"Sum, E. et al. Fibroblast activation protein \u03b1-targeted CD40 agonism abrogates systemic toxicity and enables administration of high doses to induce effective antitumor immunity. Clin. Cancer Res. 27, 4036\u20134053 (2021).","journal-title":"Clin. Cancer Res."},{"key":"747_CR101","doi-asserted-by":"publisher","first-page":"3420","DOI":"10.1158\/1078-0432.CCR-19-2238","volume":"26","author":"M Fabre","year":"2020","unstructured":"Fabre, M. et al. OMTX705, a Novel FAP-targeting ADC demonstrates activity in chemotherapy and pembrolizumab-resistant solid tumor models. Clin. Cancer Res. 26, 3420\u20133430 (2020).","journal-title":"Clin. Cancer Res."},{"key":"747_CR102","doi-asserted-by":"crossref","unstructured":"Bertero, T. et al. Tumor-stroma mechanics coordinate amino acid availability to sustain tumor growth and malignancy. Cell Metab. 29, 124\u2013140.e10 (2019).","DOI":"10.1016\/j.cmet.2018.09.012"},{"key":"747_CR103","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1038\/nature19084","volume":"536","author":"CM Sousa","year":"2016","unstructured":"Sousa, C. M. et al. Pancreatic stellate cells support tumour metabolism through autophagic alanine secretion. Nature 536, 479\u2013483 (2016).","journal-title":"Nature"},{"key":"747_CR104","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms16031","volume":"8","author":"O Olivares","year":"2017","unstructured":"Olivares, O. et al. Collagen-derived proline promotes pancreatic ductal adenocarcinoma cell survival under nutrient limited conditions. Nat. Commun. 8, 16031 (2017).","journal-title":"Nat. Commun."},{"key":"747_CR105","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1038\/nm.4073","volume":"22","author":"MJ Marakalala","year":"2016","unstructured":"Marakalala, M. J. et al. Inflammatory signaling in human tuberculosis granulomas is spatially organized. Nat. Med. 22, 531\u2013538 (2016).","journal-title":"Nat. Med."},{"key":"747_CR106","doi-asserted-by":"publisher","first-page":"eabh1623","DOI":"10.1126\/science.abh1623","volume":"376","author":"L Capolupo","year":"2022","unstructured":"Capolupo, L. et al. Sphingolipids control dermal fibroblast heterogeneity. Science 376, eabh1623 (2022).","journal-title":"Science"}],"container-title":["Cell Discovery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41421-024-00747-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41421-024-00747-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41421-024-00747-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,27]],"date-time":"2025-01-27T20:04:14Z","timestamp":1738008254000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41421-024-00747-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,28]]},"references-count":106,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["747"],"URL":"https:\/\/doi.org\/10.1038\/s41421-024-00747-z","relation":{},"ISSN":["2056-5968"],"issn-type":[{"value":"2056-5968","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,28]]},"assertion":[{"value":"22 January 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 October 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 January 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"1"}}